Wedbush initiated coverage on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a research report released on Wednesday morning, Benzinga reports. The firm issued an outperform rating and a $40.00 target price on the stock.
Oruka Therapeutics Stock Up 2.8 %
Oruka Therapeutics stock opened at $24.99 on Wednesday. Oruka Therapeutics has a 52-week low of $18.72 and a 52-week high of $53.88.
Read More
- Five stocks we like better than Oruka Therapeutics
- Profitably Trade Stocks at 52-Week Highs
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Best Stocks Under $10.00
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Oruka Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oruka Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
